IMMULITE 2000 TOXOPLASMA IGG L2KTXP

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2010-11-12 for IMMULITE 2000 TOXOPLASMA IGG L2KTXP manufactured by Siemens Healthcare Diagnostics Products Ltd.

Event Text Entries

[1742446] Discordant high toxoplasma igg results were obtained on immulite 2000 for three (3) pt samples when tested with toxo igg reagent lot 360. The initial results were reported to the physician. The lab retested the pt samples, due to the pts' histories of prior negative toxo igg results. All three (3) pt samples yielded negative results for toxoplasma igg when tested with the toxo g method on advia centaur. Pt treatment was not altered or prescribed. There were no reports of adverse health consequences due to the discordant toxo igg results.
Patient Sequence No: 1, Text Type: D, B5


[8976137] Analysis of the system data by a siemens technical service engineer (tse) indicated that there were no known causes which may have contributed to the discordant high immulite 2000 toxoplasma igg test results. The instrument is performing within specifications. No further eval of the device is required at this time.
Patient Sequence No: 1, Text Type: N, H10


[9861943] Siemens filed the initial mdr 2432235-2010-00169 on (b)(4) 2010. Updated (b)(4) 2012: it was found that a lot of bovine serum albumin (bsa) was the cause of the false positive immulite systems toxoplasma quantitative igg results, however siemens has investigated the issue and has determined that the frequency of the false positive patient results reported are within the ifu specificity claims of (b)(4) for the immulite systems toxoplasma quantitative igg assay.
Patient Sequence No: 1, Text Type: N, H10


[6373608] Discordant high toxoplasma igg results were obtained on immulite 2000 for three (3) pt samples when tested with toxo igg reagent lot 360. The initial results were reported to the physician. The lab retested the pt samples, due to the pts' histories of prior negative toxo igg results. All three (3) pt samples yielded negative results for toxoplasma igg when tested with the toxo g method on advia centaur. Pt treatment was not altered or prescribed. There were no reports of adverse health consequences due to the discordant toxo igg results.
Patient Sequence No: 2, Text Type: D, B5


[14087079] Analysis of the system data by a siemens technical service engineer (tse) indicated that there were no known causes which may have contributed to the discordant high immulite 2000 toxoplasma igg test results. The instrument is performing within specifications. No further eval of the device is required at this time.
Patient Sequence No: 2, Text Type: N, H10


[6318820] Discordant high toxoplasma igg results were obtained on immulite 2000 for three (3) pt samples when tested with toxo igg reagent lot 360. The initial results were reported to the physician. The lab retested the pt samples, due to the pts' histories of prior negative toxo igg results. All three (3) pt samples yielded negative results for toxoplasma igg when tested with the toxo g method on advia centaur. Pt treatment was not altered or prescribed. There were no reports of adverse health consequences due to the discordant toxo igg results.
Patient Sequence No: 3, Text Type: D, B5


[14313658] Analysis of the system data by a siemens technical service engineer (tse) indicated that there were no known causes which may have contributed to the discordant high immulite 2000 toxoplasma igg test results. The instrument is performing within specifications. No further eval of the device is required at this time.
Patient Sequence No: 3, Text Type: N, H10


[6342737] Discordant high toxoplasma igg results were obtained on immulite 2000 for three (3) pt samples when tested with toxo igg reagent lot 360. The initial results were reported to the physician. The lab retested the pt samples, due to the pts' histories of prior negative toxo igg results. All three (3) pt samples yielded negative results for toxoplasma igg when tested with the toxo g method on advia centaur. Pt treatment was not altered or prescribed. There were no reports of adverse health consequences due to the discordant toxo igg results.
Patient Sequence No: 4, Text Type: D, B5


[13515658] Analysis of the system data by a siemens technical service engineer (tse) indicated that there were no known causes which may have contributed to the discordant high immulite 2000 toxoplasma igg test results. The instrument is performing within specifications. No further eval of the device is required at this time.
Patient Sequence No: 4, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2010-00169
MDR Report Key1902399
Report Source05,06
Date Received2010-11-12
Date Mfgr Received2011-09-01
Date Added to Maude2012-03-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactBARBARA KVASNOSKY
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145243658
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS
Manufacturer StreetGLYN RHONWY LLANBERIS
Manufacturer CityGWYNEDD, WALES LL554EL
Manufacturer CountryUK
Manufacturer Postal CodeLL55 4EL
Single Use3
Remedial ActionOT
Previous Use Code3
Removal Correction NumberN/A
Event Type3
Type of Report3

Device Details

Brand NameIMMULITE 2000 TOXOPLASMA IGG
Generic NameTOXOPLASMA GONDII IMMUNOASSAY
Product CodeDGC
Date Received2010-11-12
Model NumberNA
Catalog NumberL2KTXP
Lot Number360
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD
Manufacturer AddressLANBERIS, GWYNEDD WALES LL554EL UK LL55 4EL


Patients

Patient NumberTreatmentOutcomeDate
10 2010-11-12
20 2010-11-12
30 2010-11-12
40 2010-11-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.